← Open Payments lookup

MELINDA ZAMORA: Open Payments

NPI 1184351330 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,276 in 91 payments from 13 companies in 2025. Trend: 2023 $975 · 2024 $872 · 2025 $2,276

Food & beverage: $2,264Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$534
Supernus Pharmaceuticals, Inc.35$312
E.R. Squibb & Sons, L.L.C.5$290
Axsome Therapeutics, Inc.6$289
ABBVIE INC.12$276
Teva Pharmaceuticals USA, Inc.6$193
Neurocrine BioSciences, Inc.3$185
Otsuka America Pharmaceutical, Inc.4$68
Medtronic, Inc.1$43
Lundbeck LLC2$37

Products named: CAPLYTA, Qelbree, COBENFY, Auvelity, VRAYLAR, INGREZZA, UZEDY, REXULTI.

Industry payments across TX — which companies pay providers there.